TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company’s Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company (reduced from a majority of such shares). The amended provision of the Amended and Restated By-Laws is Section 5 of Article I. The Company’s Amended and Restated By-Laws provide that an amendment may be made by a majority of the independent directors, who adopted this change unanimously. The reduction in the quorum requirement, which is permitted under Delaware law and the rules and regulations of the Nasdaq Stock Market, will now make it easier for the Company to convene and conduct stockholders’ meetings, including annual meetings.
